Category Archives: Recent News

BriaCell Therapeutics Corp. to Present at The MicroCap Conference on June 21st in Toronto at the Sheraton Centre Hotel
June 13, 2018

(Accesswire — June 13, 2018) – BriaCell Therapeutics Corp. (“BriaCell”) (TSX-V: BCT) (OTCQB:BCTXF), an immuno-oncology ...

BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting
May 29, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell’s Lead Product Candidate’s Novel Mechanism of Action Published in a Reputable Immunology Journal
May 21, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, May 21, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer
April 23, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, April 23, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Provides Highlights of Scientific and Clinical Findings at AACR
April 18, 2018

– Early data points to safety and early efficacy of Bria-IMT™ in Advanced Stage IV ...

BriaCell to Present Encouraging Clinical Data at AACR 2018
April 10, 2018

– Early Evidence of Safety and Impressive Anti-Tumor Activity of Bria-IMT™- BERKELEY, Calif. and VANCOUVER, ...

BriaCell’s Lead Product Candidate Mechanism of Action Described in a Major Immunology Journal
April 3, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, April 3, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Completes Previously Announced Oversubscribed Non-Brokered Private Placement and Concurrent Investment with Leading U.S. Biotech Funds
March 28, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, March 27, 2018 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Appoints Top Social Media Marketing Analyst
March 14, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, March 14, 2018 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

BriaCell Announces Proposed Investment by Leading Biotech Funds and Concurrent Non-Brokered Financing for aggregate gross proceeds of up to $4.8 Million
March 9, 2018

BERKELEY, Calif. and VANCOUVER, British Columbia, March 07, 2018 –BriaCell Therapeutics Corp. (“BriaCell” or the ...